Pharmacologic vitreolysis.
The vitreoretinal interface is involved in a wide range of vitreoretinal disorders and separation of the posterior vitreous face from the retinal surface is an essential part of vitrectomy surgeries. A diverse range of enzymatic and non-enzymatic agents are being studied as an adjunct before or during vitrectomy to facilitate the induction of posterior vitreous detachment. There is a significant body of knowledge in the literature about different vitreolytic agents under investigation for a variety of pathologies involving the vitreoretinal interface which will be summarized in this review.
Eye Research Center, Iran University of Medical Sciences, Tehran, Iran.
Hossein
H
Nazari
Mehdi
M
Modarres-Zadeh
Arash
A
Maleki